A detailed history of Twin Lakes Capital Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 2,171 shares of JAZZ stock, worth $239,786. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,171
Previous 2,171 -0.0%
Holding current value
$239,786
Previous $261,000 11.49%
% of portfolio
0.16%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$114.26 - $136.0 $114,260 - $136,000
-1,000 Reduced 31.54%
2,171 $267,000
Q4 2022

Feb 03, 2023

SELL
$129.72 - $159.85 $7,912 - $9,750
-61 Reduced 1.89%
3,171 $505,000
Q3 2022

Oct 21, 2022

BUY
$126.59 - $161.18 $409,138 - $520,933
3,232 New
3,232 $431,000
Q2 2022

Aug 15, 2022

SELL
$141.59 - $168.66 $472,485 - $562,818
-3,337 Closed
0 $0
Q4 2020

Feb 26, 2021

BUY
$140.71 - $165.05 $469,549 - $550,771
3,337 New
3,337 $551,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.92B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Twin Lakes Capital Management, LLC Portfolio

Follow Twin Lakes Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Lakes Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Lakes Capital Management, LLC with notifications on news.